Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $35.00 to $39.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 169.34% from the […]
Syndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report) had its price target lifted by analysts at JPMorgan Chase & Co. from $35.00 to $39.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 169.34% from the […]
